anti-citrullinated protein antibodies

Shift in perspective: autoimmunity protecting against rheumatoid arthritis
Yibo He, Mike Aoun, Zhongwei Xu, Rikard Holmdahl

Annals of the Rheumatic Diseases May 2024, 83 (5) 550-555; DOI: 10.1136/ard-2023-225237
Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?
Diane van der Woude, René E M Toes

Annals of the Rheumatic Diseases Feb 2024, ard-2023-224103; DOI: 10.1136/ard-2023-224103
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation
Eleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, Lars Klareskog, Lars Alfredsson, Linda Mathsson-Alm, Monika Hansson, Martin Cornillet, Guy Serre, Rikard Holmdahl, Karl Skriner, Per-Johan Jakobsson, Helga Westerlind, Johan Askling, Johan Rönnelid

Annals of the Rheumatic Diseases Mar 2024, 83 (3) 277-287; DOI: 10.1136/ard-2023-224728
IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis
Tineke J van Wesemael, Sanne Reijm, Atsushi Kawakami, Annemarie L Dorjée, Gerrie Stoeken, Takahiro Maeda, Shin-ya Kawashiri, Tom W J Huizinga, Mami Tamai, René E M Toes, Diane van der Woude

Annals of the Rheumatic Diseases Feb 2024, 83 (2) 267-270; DOI: 10.1136/ard-2023-224553
Low avidity observed for anti-citrullinated peptide antibody is not a general phenomenon for autoantibodies
Hisakata Yamada, Akihisa Haraguchi, Tomomi Tsuru, Masakazu Kondo, Fumiaki Sagawa, Hiroaki Niiro, Yasuharu Nakashima

Annals of the Rheumatic Diseases Dec 2023, 82 (12) 1637-1638; DOI: 10.1136/ard-2023-224303
Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis
Yoon Y Qiu, Tuhina Neogi, Lutfiyya N Muhammad, Jing Song, Marcy B Bolster, Wendy Marder, Andrew C Heisler, Alyssa Wohlfahrt, Dorothy Dunlop, Yvonne C Lee

Annals of the Rheumatic Diseases Dec 2023, 82 (12) 1638-1640; DOI: 10.1136/ard-2023-224492
Correspondence on ‘Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting’
Marc Scherlinger, Thierry Schaeverbeke

Annals of the Rheumatic Diseases Nov 2023, 82 (11) e221; DOI: 10.1136/annrheumdis-2021-220345
No excess mortality in contemporary undifferentiated arthritis, in contrast to rheumatoid arthritis: a study with a follow-up of at least 10 years
Marloes Verstappen, Tom WJ Huizinga, Annette HM van der Helm-van Mil

Annals of the Rheumatic Diseases Aug 2022, 81 (8) 1197-1199; DOI: 10.1136/annrheumdis-2022-222145
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis
Serena Bugatti, Ludovico De Stefano, Bernardo D’Onofrio, Andrea Nicrosini, Eleonora Mauric, Michele di Lernia, Garifallia Sakellariou, Ennio Giulio Favalli, Antonio Manzo, Roberto Caporali, Carlomaurizio Montecucco

Annals of the Rheumatic Diseases Sep 2022, 81 (9) 1206-1213; DOI: 10.1136/annrheumdis-2022-222436
Response to: ‘Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a ‘mix-and-match’ approach’ by Alunno et al
Raul Castellanos-Moreira, Sebastian Cruz Rodríguez-García, Isabel Haro, Raimon Sanmarti

Annals of the Rheumatic Diseases Apr 2022, 81 (4) e54; DOI: 10.1136/annrheumdis-2020-217432

Main menu

anti-citrullinated protein antibodies

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

anti-citrullinated protein antibodies

Pages